300601 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shenzhen Kangtai Biological Products Co., Ltd. engages in the manufacture, sale, and research and development of human vaccines. Its products include cell free haemophilus infuenzae type b vaccine, measles rubella vaccine, haemophilus influenzae type b conjugate vaccine, recombinant hepatitis B vaccine, and liver vaccine. The company was founded on September 8, 1992 and is headquartered in Shenzhen, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
300601 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company